| 1 | [SID103713949] | Active | EC50 | 0.02165 | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay [AID449703, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103713949 | | CID | 2900 | | Outcome | Active | | EC50 | 0.02165 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | | AID | 449703 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103713949] | Active | EC50 | 0.0675 | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay [AID449704, Type: other] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103713949 | | CID | 2900 | | Outcome | Active | | EC50 | 0.0675 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | | AID | 449704 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID103714034] | Active | EC50 | 0.1526 | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay [AID449703, Type: other] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103714034 | | CID | 2900 | | Outcome | Active | | EC50 | 0.1526 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | | AID | 449703 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID103713949] | Active | CC50 | 0.3043 | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) [AID449705, Type: other] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103713949 | | CID | 2900 | | Outcome | Active | | CC50 | 0.3043 [uM] | | BioAssay | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | | AID | 449705 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID103714034] | Active | EC50 | 0.366 | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay [AID449704, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103714034 | | CID | 2900 | | Outcome | Active | | EC50 | 0.366 [uM] | | BioAssay | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | | AID | 449704 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID124893560] | Active | Potency | 1.0859 | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. [AID624479, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Active | | Potency | 1.0859 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. | | AID | 624479 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID124893560] | Active | Potency | 1.9144 | Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs) [AID651712, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Active | | Potency | 1.9144 [uM] | | BioAssay | Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs) | | AID | 651712 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID103714034] | Active | CC50 | 2.144 | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) [AID449705, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103714034 | | CID | 2900 | | Outcome | Active | | CC50 | 2.144 [uM] | | BioAssay | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | | AID | 449705 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID124893560] | Active | Potency | 17.0619 | Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs) [AID651713, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Active | | Potency | 17.0619 [uM] | | BioAssay | Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs) | | AID | 651713 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID103714034] | Unspecified | | | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. [AID449706, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103714034 | | CID | 2900 | | Outcome | Unspecified | | BioAssay | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. | | AID | 449706 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID103713949] | Unspecified | | | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. [AID449706, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103713949 | | CID | 2900 | | Outcome | Unspecified | | BioAssay | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. | | AID | 449706 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID124893560] | Inactive | Potency | 0.0605 | Cell Proliferation Assay against the HBL1 Cell Line [AID651646, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | 0.0605 [uM] | | BioAssay | Cell Proliferation Assay against the HBL1 Cell Line | | AID | 651646 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID124893560] | Inactive | Potency | 1.7062 | Cell Proliferation Assay against a hMSC Cell Line [AID651696, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | 1.7062 [uM] | | BioAssay | Cell Proliferation Assay against a hMSC Cell Line | | AID | 651696 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID124893560] | Inactive | Potency | | Cell Proliferation Assay against the TMD8 Cell Line [AID651645, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Proliferation Assay against the TMD8 Cell Line | | AID | 651645 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID124893560] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 16 | [SID124893560] | Inactive | Potency | | qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. [AID624478, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. | | AID | 624478 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID124893560] | Inactive | Potency | | Cytotoxicity counterscreen for NFkB agonists and antagonists [AID624476, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124893560 | | CID | 2900 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cytotoxicity counterscreen for NFkB agonists and antagonists | | AID | 624476 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|